151 related articles for article (PubMed ID: 2112168)
1. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection.
Rode H; de Wet PM; Millar AJ; Cywes S
J Antimicrob Chemother; 1988 May; 21(5):589-95. PubMed ID: 3134320
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus resistant to mupirocin.
Smith GE; Kennedy CT
J Antimicrob Chemother; 1988 Jan; 21(1):141-2. PubMed ID: 3128519
[No Abstract] [Full Text] [Related]
4. Mupirocin: a new topical antibiotic.
Leyden JJ
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165
[TBL] [Abstract][Full Text] [Related]
5. The clinical development of mupirocin.
Pappa KA
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164
[TBL] [Abstract][Full Text] [Related]
6. Use of mupirocin ointment in the treatment of secondarily infected dermatoses.
Breneman DL
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167
[TBL] [Abstract][Full Text] [Related]
7. Treatment of junctional epidermolysis bullosa with epidermal autografts.
Carter DM; Lin AN; Varghese MC; Caldwell D; Pratt LA; Eisinger M
J Am Acad Dermatol; 1987 Aug; 17(2 Pt 1):246-50. PubMed ID: 3114337
[TBL] [Abstract][Full Text] [Related]
8. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database.
Levin LE; Shayegan LH; Lucky AW; Hook KP; Bruckner AL; Feinstein JA; Whittier S; Lauren CT; Pope E; Lara-Corrales I; Wiss K; McCuaig CC; Powell J; Eichenfield LF; Levy ML; Diaz L; Glick SA; Paller AS; Price HN; Browning JC; Morel KD
Pediatr Dermatol; 2021 Jan; 38(1):119-124. PubMed ID: 33247481
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.
Rode H; Hanslo D; de Wet PM; Millar AJ; Cywes S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1358-61. PubMed ID: 2508545
[TBL] [Abstract][Full Text] [Related]
10. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis.
Luber H; Amornsiripanitch S; Lucky AW
Arch Dermatol; 1988 Jun; 124(6):853-4. PubMed ID: 3132108
[No Abstract] [Full Text] [Related]
11. Wound culture isolated antibiograms and caregiver-reported skin care practices in children with epidermolysis bullosa.
Singer HM; Levin LE; Garzon MC; Lauren CT; Planet PJ; Kittler NW; Whittier S; Morel KD
Pediatr Dermatol; 2018 Jan; 35(1):92-96. PubMed ID: 29105824
[TBL] [Abstract][Full Text] [Related]
12. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
[TBL] [Abstract][Full Text] [Related]
13. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
McLinn S
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma pathophysiology and management.
Leyden JJ
Arch Dermatol; 1988 May; 124(5):753-5. PubMed ID: 3129996
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
[TBL] [Abstract][Full Text] [Related]
16. The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals.
Gordon RJ; Chez N; Jia H; Zeller B; Sobieszczyk M; Brennan C; Hisert KB; Lee MH; Vavagiakis P; Lowy FD
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):466-72. PubMed ID: 20686410
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
[TBL] [Abstract][Full Text] [Related]
18. Neomycin Sulfate Improves the Antimicrobial Activity of Mupirocin-Based Antibacterial Ointments.
Blanchard C; Brooks L; Beckley A; Colquhoun J; Dewhurst S; Dunman PM
Antimicrob Agents Chemother; 2016 Feb; 60(2):862-72. PubMed ID: 26596945
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of dialkylcarbamoylchloride-coated cotton acetate dressing versus combination of normal saline dressing and 2% mupirocin ointment in infected wounds of epidermolysis bullosa.
Dwiyana RF; Gondokaryono SP; Rahardja JI; Arline Diana I; Yogya Y; Gunawan H
Dermatol Ther; 2019 Sep; 32(5):e13047. PubMed ID: 31369180
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
